// App-Quantinova.ai

: Risk Factors for Major Adverse Cardiac Events and Bleeding in Patients with Myeloproliferative Neoplasms Admitted for Myocardial Infarction

Researchers

Presenter

  • Orly Leiva

Principal Investigators

  • Emaad Siddiqui

  • Gabriela S. Hobbs

  • Sripal Bangalore

Medical Centers

  • Division of Cardiovascular Medicine, Department of Medicine, New York University Grossman School of Medicine, New York City, NY

  • New York University Grossman School of Medicine, New York City, NY

  • Cancer Center, Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Nephrology

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myeloid neoplasms

  • Coronary Artery Disease

  • Myocardial infarction

  • Peptic ulcer

  • Arrhythmia

  • Diabetes

  • Venous thrombosis

  • Cardiogenic shock

  • Cardiac arrest

  • Congestive heart failure

  • Renal insufficiency

  • Hypertension

  • Obesity

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved